MSB 2.10% $1.17 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-744

  1. 2,261 Posts.
    lightbulb Created with Sketch. 367
    thanks @Malown1 and @Armyne although apparently according to@Commomo I am a loser for posting it as its "old news".
    Thanks to @imback for digging it up back then as well.Yes it would be intersting if that one got out onto the Facebook page of the parents with kids with terminal GVHD support group wouldnt it!?? would not play well for Novaretis or the FDA, no wonder the ODAC language in the transcript was so defensive from the start " we are here to make sure children cant be harmed by unproven medicines" even though they are already dying with no other viable options.

    I suspect a deal will be forthcoming which makes me more positive towards Novartis partnering chances and GVHD chance now? Maybe I am being niaive or too hopeful but.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.